Skip to main content

Published locations for Abrocitinib more promising than dupilumab in moderate-to-severe atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Abrocitinib more promising than dupilumab in moderate-to-severe atopic dermatitis

User login

  • Reset your password
  • /content/abrocitinib-more-promising-dupilumab-moderate-severe-atopic-dermatitis
  • /dermatology/article/257198/atopic-dermatitis/abrocitinib-more-promising-dupilumab-moderate-severe